Arhaus vs RH
ARHS and RH side by side, both in consumer discretionary. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARHS and RH compare
RH is the larger company, worth 1.6 times as much as Arhaus ($2.8B against $1.8B).
On earnings, Arhaus is cheaper: it trades at 24.9× trailing earnings, against 26.1× for RH.
Arhaus grew revenue faster over the last twelve months (5.4% versus 3.3% for RH).
Arhaus keeps more of each dollar of sales as profit, with a net margin of 4.9% compared with 3.2% at RH.
Arhaus pays a dividend yielding 2.8%; RH does not pay one.
Arhaus scores higher on the StockData Score (15 against 12 for RH), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARHS | RH |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $2.8B |
| Share price | $12.45 | $146.66 |
| Change, 1 year | 22.4% | −20.4% |
| Change, 5 years | 2.0% | −77.8% |
| Beta (5Y) | 1.97 | 2.21 |
| Employees | 2,800 | 6,500 |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 0 | 3 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 2 |
| Health score | 5 | 5 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 24.9× (better) | 26.1× |
| P/S | 1.3× | 0.8× (better) |
| P/B | 4.3× (better) | 23.1× |
| EV/EBITDA | 10.8× | 5.3× (better) |
| P/FCF | 43.2× | 11.1× (better) |
| FCF yield | 2.3% | 9.0% (better) |
| Fair value | $9.52 | $175.24 |
| Margin of safety | −30.8% | 16.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.4% (better) | 3.3% |
| Revenue growth, 5Y average | 22.1% (better) | 3.8% |
| Net income growth (TTM) | −2.8% | 4.4% (better) |
| EPS growth (TTM) | 0.00% | 4.7% (better) |
| EPS growth, 5Y average | 74.1% (better) | −8.7% |
| Profitability | ||
| Gross margin | 39.7% | 44.3% (better) |
| Operating margin | 6.6% | 10.0% (better) |
| Net margin | 4.9% (better) | 3.2% |
| FCF margin | 2.9% | 7.3% (better) |
| Return on equity | 17.3% | 281% (better) |
| Return on invested capital | 39.5% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.33 (better) | 1.12 |
| Altman Z-score | 2.53 (better) | 1.16 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.8% | – |
| Payout ratio | 71.8% | – |
| Shareholder yield | 2.8% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 37.9% | 105% |
| Held by insiders | 1.7% | 27.1% |
| Insider net buying, 12 months | −$29.6K (better) | −$24.6M |
| Short interest, % of float | 4.3% | 38.3% |
Go deeper
- ARHS stock overview
- ARHS income statement
- ARHS valuation and score
- RH stock overview
- RH income statement
- RH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.